Sundarrajan Thirugnanasambandam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sundarrajan Thirugnanasambandam has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Anguraj Moulishankar
2 shared publications- Anguraj Moulishankar
Department of Pharmaceutical Chemistry, Integrated Drug Discovery Centre Acharya & BM Reddy College of Pharmacy Bengaluru Karnataka India
2 shared publications - Anitha K N
Department of Pharmacology, Government College of Pharmacy Bengaluru-560027 Karnataka India
1 shared publication Arbinda Ghosh
Department of Botany, Microbiology Division, Gauhati University, Guwahati, Assam
1 shared publicationDhanalakshmi Mohanradja
Department of Pharmaceutical Analysis, SMVEC Pharmacy College, Madagadipet 605107, Puducherry, India
1 shared publicationDurga Prasad Kondeti
SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Tamil Nadu
1 shared publication
Latest Publications
- Open Access
- 6 July 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Pharmacophore-based virtual screening, molecular docking, MD simulation, MM-GBSA energy calculation and DFT analysis for the in silico discovery of a SaFtsZ inhibitor.
The rapid emergence of antimicrobial resistance demands the discovery of new antibacterial targets and inhibitors. Staphylococcus aureus filamenting temperature-sensitive protein (SaFtsZ), an essential cytoskeletal protein involved in bacterial cytokinesis and Z-ring formation, has gained attention as a promising target for antibacterial drug discovery. In the present study, an integrated computational strategy involving pharmacophore mapping, molecular docking, molecular dynamics (MD) simulations, and density functional theory (DFT) analysis was employed to identify potential SaFtsZ inhibitors. Initially, large compound library was screened from the Pharmit database using a structure-based pharmacophore model to identify molecules with key interaction features required for SaFtsZ inhibition. The selected 200 candidates were further evaluated through molecular docking to determine their binding affinity and interaction pattern within the active site of SaFtsZ. Among the screened molecules, compound 15 (CID 135468497) exhibited the highest binding affinity with a docking score of -10.8 kcal mol-1. Subsequent MD simulation confirmed the stability of the protein-ligand complex, while DFT analysis provided insights into the electronic characteristics and reactivity of compound 15. These findings highlight compound 15 as a computationally predicted scaffold for the development of SaFtsZ-targeted antibacterial agents. However, experimental validation is required to confirm the computational results.
- 6 July 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessPharmacophore-based virtual screening, molecular docking, MD simulation, MM-GBSA energy calculation and DFT analysis for the in silico discovery of a SaFtsZ inhibitor.
The rapid emergence of antimicrobial resistance demands the discovery of new antibacterial targets and inhibitors. Staphylococcus aureus filamenting temperature-sensitive protein (SaFtsZ), an essential cytoskeletal protein involved in bacterial cytokinesis and Z-ring formation, has gained attention as a promising target for antibacterial drug discovery. In the present study, an integrated computational strategy involving pharmacophore mapping, molecular docking, molecular dynamics (MD) simulations, and density functional theory (DFT) analysis was employed to identify potential SaFtsZ inhibitors. Initially, large compound library was screened from the Pharmit database using a structure-based pharmacophore model to identify molecules with key interaction features required for SaFtsZ inhibition. The selected 200 candidates were further evaluated through molecular docking to determine their binding affinity and interaction pattern within the active site of SaFtsZ. Among the screened molecules, compound 15 (CID 135468497) exhibited the highest binding affinity with a docking score of -10.8 kcal mol-1. Subsequent MD simulation confirmed the stability of the protein-ligand complex, while DFT analysis provided insights into the electronic characteristics and reactivity of compound 15. These findings highlight compound 15 as a computationally predicted scaffold for the development of SaFtsZ-targeted antibacterial agents. However, experimental validation is required to confirm the computational results.
- Open Access
- 14 May 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (19) , e01761
Network Pharmacology and Molecular Dynamics Simulation‐Based Elucidation of the Anti‐Alzheimer's Potential of Bacopa Monnieri Phytochemicals
Alzheimer's disease (AD) is a progressive neurological condition marked by cognitive deterioration and restricted treatment alternatives. This study investigated Bacopa monnieri , a traditional medicinal herb recognized for its neuroprotective characteristics, to assess its therapeutic potential against Alzheimer's disease by in silico methods. A network pharmacology approach was utilized to discover targets related to Alzheimer's disease, with CASP3 and APP identified as pivotal nodes. Molecular docking study revealed that three phytochemicals—Luteolin, Apigenin, displayed significant binding affinities for these targets. Moreover, molecular dynamics (MD) simulations confirmed the stability of the ligand–protein interactions throughout time, affirming advantageous conformational behavior. The ADMET study demonstrated satisfactory pharmacokinetic and drug‐likeness characteristics for the phytoconstituents. The results indicate that phytochemicals from B. monnieri , specifically Luteolin and Apigenin, exhibit promise as lead molecules for additional research and development in Alzheimer's disease therapies. Using cutting‐edge computational tools, this study was planned as a thorough in silico investigation that would effectively screen and analyze phytoconstituents and their molecular targets. The results provide a solid basis for upcoming in vitro and in vivo validations, even though the current phase concentrates on computational techniques.
- 14 May 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (19) , e01761
Open AccessNetwork Pharmacology and Molecular Dynamics Simulation‐Based Elucidation of the Anti‐Alzheimer's Potential of Bacopa Monnieri Phytochemicals
Alzheimer's disease (AD) is a progressive neurological condition marked by cognitive deterioration and restricted treatment alternatives. This study investigated Bacopa monnieri , a traditional medicinal herb recognized for its neuroprotective characteristics, to assess its therapeutic potential against Alzheimer's disease by in silico methods. A network pharmacology approach was utilized to discover targets related to Alzheimer's disease, with CASP3 and APP identified as pivotal nodes. Molecular docking study revealed that three phytochemicals—Luteolin, Apigenin, displayed significant binding affinities for these targets. Moreover, molecular dynamics (MD) simulations confirmed the stability of the ligand–protein interactions throughout time, affirming advantageous conformational behavior. The ADMET study demonstrated satisfactory pharmacokinetic and drug‐likeness characteristics for the phytoconstituents. The results indicate that phytochemicals from B. monnieri , specifically Luteolin and Apigenin, exhibit promise as lead molecules for additional research and development in Alzheimer's disease therapies. Using cutting‐edge computational tools, this study was planned as a thorough in silico investigation that would effectively screen and analyze phytoconstituents and their molecular targets. The results provide a solid basis for upcoming in vitro and in vivo validations, even though the current phase concentrates on computational techniques.
- 10 November 2024
- Published by Elsevier in Acta Tropica
- Vol. 260, 107460
Identification of novel DNA gyrase inhibitor by combined pharmacophore modeling, QSAR analysis, molecular docking, molecular dynamics, ADMET and DFT approaches
- 10 November 2024
- Published by Elsevier in Acta Tropica
- Vol. 260, 107460
Identification of novel DNA gyrase inhibitor by combined pharmacophore modeling, QSAR analysis, molecular docking, molecular dynamics, ADMET and DFT approaches
- Open Access
- 31 July 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1537-1545
Development and Characterisation of Curcuminoid Loaded Hydrogel for the Effective Treatment of Diabetic Retinopathy
Background: The leading cause of vision loss in individuals with diabetes worldwide is diabetic retinopathy. A curcuminoid-loaded hydro gel has been proposed to improve solubility and ocular permeation. Aim: A gel-based formulation using gellan gum was hypothesised to enhance its bioavailability. The RP-HPLC analysis confirmed curcuminoid isolated from raw turmeric. Methods: By varying the gellan gum concentrations, three different formulations were developed. The developed curcuminoid-loaded gel formulation was further characterised by its FT-IR signature analysis, particle size, zeta potential, morphology and in-vitro release behaviour. Results: The signature analysis results indicate a drug’s signature in the formulation. The study revealed sphere-sized particles ranging from 6387±113 to 4595±184 nm with zeta potential ranging from -21 ±2.29 mV to -19.6 ±3.19 mV. A sustained release pattern was observed by the in-vitro release studies. The results of ex vivo corneal permeation studies indicate that the developed curcuminoid loaded hydrogel have some exposure to the posterior segment of the eye. Conclusion: To conclude the developed curcuminoid hydrogel may provide exposure to the posterior segment of the eye due to its significant corneal permeation property.
- 31 July 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1537-1545
Open AccessDevelopment and Characterisation of Curcuminoid Loaded Hydrogel for the Effective Treatment of Diabetic Retinopathy
Background: The leading cause of vision loss in individuals with diabetes worldwide is diabetic retinopathy. A curcuminoid-loaded hydro gel has been proposed to improve solubility and ocular permeation. Aim: A gel-based formulation using gellan gum was hypothesised to enhance its bioavailability. The RP-HPLC analysis confirmed curcuminoid isolated from raw turmeric. Methods: By varying the gellan gum concentrations, three different formulations were developed. The developed curcuminoid-loaded gel formulation was further characterised by its FT-IR signature analysis, particle size, zeta potential, morphology and in-vitro release behaviour. Results: The signature analysis results indicate a drug’s signature in the formulation. The study revealed sphere-sized particles ranging from 6387±113 to 4595±184 nm with zeta potential ranging from -21 ±2.29 mV to -19.6 ±3.19 mV. A sustained release pattern was observed by the in-vitro release studies. The results of ex vivo corneal permeation studies indicate that the developed curcuminoid loaded hydrogel have some exposure to the posterior segment of the eye. Conclusion: To conclude the developed curcuminoid hydrogel may provide exposure to the posterior segment of the eye due to its significant corneal permeation property.
- Open Access
- 8 February 2024
- Published by Elsevier in Chemical Physics Impact
- Vol. 8
Pharmacophore, QSAR, molecular docking, molecular dynamics and ADMET study of trisubstituted benzimidazole derivatives as potent anti-tubercular agents
- 8 February 2024
- Published by Elsevier in Chemical Physics Impact
- Vol. 8
Open AccessPharmacophore, QSAR, molecular docking, molecular dynamics and ADMET study of trisubstituted benzimidazole derivatives as potent anti-tubercular agents
- Open Access
- 29 November 2023
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 12 (1) , 1-20
QSAR modeling, molecular docking, dynamic simulation and ADMET study of novel tetrahydronaphthalene derivatives as potent antitubercular agents
Background: Tuberculosis is an air-borne contagious disease caused by slow-growing Mycobacterium tuberculosis (Mtb). According to Global Tuberculosis Report 2022, 1.6 million people were infected by tuberculosis in 2021. The continuing spread of drug-resistant tuberculosis (TB) is one of the most difficult challenges to control the tuberculosis. So new drug discovery is essential to the treatment of tuberculosis. This study aims to develop a QSAR model to predict the antitubercular activity of tetrahydronaphthalene derivatives. The QSARINS was used in this study to develop the QSAR predictive model. Results: A number of tetrahydronaphthalene derivatives with MIC90 values were obtained from the literature to develop the QSAR predictive model. The compounds were divided into two sets: a training set consisting of 39 compounds and a test set containing 13 compounds. The best predictive Model 4 has R2: 0.8303, Q2LOO: 0.7642, LOF: 0.0550, Q2-F1: 0.7190, Q2-F2: 0.7067, Q2-F3: 0.7938 and CCCext: 0.8720. Based on the developed QSAR equation, the new compounds were designed and subjected to molecular docking, molecular dynamics and ADMET analysis. Conclusion: In the QSAR model, the molecular descriptors of MATS8s, Chi4, bcutv8, Petitjeant and fr_aniline were highly influenced the antitubercular activity. The developed QSAR model helps to predict the antitubercular activity of tetrahydronaphthalene derivatives.
- 29 November 2023
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 12 (1) , 1-20
Open AccessQSAR modeling, molecular docking, dynamic simulation and ADMET study of novel tetrahydronaphthalene derivatives as potent antitubercular agents
Background: Tuberculosis is an air-borne contagious disease caused by slow-growing Mycobacterium tuberculosis (Mtb). According to Global Tuberculosis Report 2022, 1.6 million people were infected by tuberculosis in 2021. The continuing spread of drug-resistant tuberculosis (TB) is one of the most difficult challenges to control the tuberculosis. So new drug discovery is essential to the treatment of tuberculosis. This study aims to develop a QSAR model to predict the antitubercular activity of tetrahydronaphthalene derivatives. The QSARINS was used in this study to develop the QSAR predictive model. Results: A number of tetrahydronaphthalene derivatives with MIC90 values were obtained from the literature to develop the QSAR predictive model. The compounds were divided into two sets: a training set consisting of 39 compounds and a test set containing 13 compounds. The best predictive Model 4 has R2: 0.8303, Q2LOO: 0.7642, LOF: 0.0550, Q2-F1: 0.7190, Q2-F2: 0.7067, Q2-F3: 0.7938 and CCCext: 0.8720. Based on the developed QSAR equation, the new compounds were designed and subjected to molecular docking, molecular dynamics and ADMET analysis. Conclusion: In the QSAR model, the molecular descriptors of MATS8s, Chi4, bcutv8, Petitjeant and fr_aniline were highly influenced the antitubercular activity. The developed QSAR model helps to predict the antitubercular activity of tetrahydronaphthalene derivatives.
- Open Access
- 1 February 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (2) , 134-137
Yellow fever virus, a mosquito-borne flavivirus posing high public health concerns and imminent threats to travellers – an update
- 1 February 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (2) , 134-137
Open AccessYellow fever virus, a mosquito-borne flavivirus posing high public health concerns and imminent threats to travellers – an update
- Open Access
- 1 December 2019
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 11 (6s) , 1540-1543
The Effect of Ultraviolet-B Radiation Exposure on Hibiscus cannabinus Linn with its Phytochemical and Pharmacological Responses
Protein content determined by Lowry et al. method. 0.5 gm of
- 1 December 2019
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 11 (6s) , 1540-1543
Open AccessThe Effect of Ultraviolet-B Radiation Exposure on Hibiscus cannabinus Linn with its Phytochemical and Pharmacological Responses
Protein content determined by Lowry et al. method. 0.5 gm of